Introduction：Basic information about EPA CAS 73167-03-0, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
EPA Basic information
| Product Name: | EPA |
| Synonyms: | 5C,8C,11C,14C,17C-EICOSAPENTAENOIC ACID;5,8,11,14,17-EICOSAPENTAENOIC ACID;5Z,8Z,11Z,14Z,17Z-EICOSAPENTAENOIC ACID;ALL CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID;ALL CIS 5-8-11-14-17 EPA;ALL CIS-5,8,11,14,17-ICOSAPENTAENOIC ACID;C20:5 (ALL CIS-5,8,11,14,17) ACID;C20:5 OMEGA-3 |
| CAS: | 73167-03-0 |
| MF: | C20H29O2.Na |
| MW: | 324.44 |
| EINECS: | |
| Product Categories: | Lipoxygenase (5-)Unsaturated fatty acids and derivatives;LipoxygenaseEnzyme Inhibitors by Enzyme;Omega 3 fatty acids and derivativesBiochemicals Found in Plants;Arachidonic Acid Cascade;Enzyme Inhibitors;L to;Lipids;Polyunsaturated |
| Mol File: | 73167-03-0.mol |
|
EPA Chemical Properties
| Melting point | −54-−53 °C(lit.) |
| density | 0.943 g/mL at 25 °C(lit.) |
| refractive index | n20/D 1.4977(lit.) |
| storage temp. | -20°C |
| solubility | Ethanol: 1.5 mg/ml; Ethanol:PBS(pH 7.2) (1:5): 0.5 mg/ml |
| form | waxy solid |
| color | white |
| biological source | synthetic (organic) |
| InChIKey | TVEGTERCKGGVCJ-LIJGWLRISA-N |
| SMILES | [Na].CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O |
Safety Information
| Hazard Codes | C |
| Risk Statements | 34 |
| Safety Statements | 26-36/37/39-45 |
| RIDADR | UN 3265 8/PG 3 |
| WGK Germany | 3 |
| F | 8-10-23 |
| Storage Class | 11 - Combustible Solids |
EPA Usage And Synthesis
| Uses | reduces thromboxane A2 production and platelet aggregation, inhibits 5-lipoxygenase and prevents arteriosclerosis. |
| Uses | cis-5,8,11,14,17-Eicosapentaenoic acid sodium salt has been used:
- to study its effect on the pathology of lupus in drug-induced and spontaneous mouse models
- to pretreat mouse alveolar macrophages to study the effect/relationship between amiodarone and eicosapentaenoic acid (EPA) concerning the cytokine release
- to examine if pharmacological correction with EPA supplementation might restore autophagic flux and reduce renal lipotoxicity in mice
|
| General Description | Eicosapentaenoic acid (EPA)/timnodonic acid is an omega-3 polyunsaturated fatty acid (PUFA). This long-chain fatty acid is mainly found in fish oil. |
| Biochem/physiol Actions | Eicosapentaenoic acid (EPA) possesses anti-hyperglycemic, anti-oxidant, anti-hyperlipidemic, and anti-inflammatory properties. It aids in improving vasoreactivity. EPA is capable of suppressing vascular smooth muscle proliferation. It ameliorates pulmonary hypertension by preventing Fyn kinase activity. EPA exhibits a beneficial effect on lipid metabolism. It is used to treat hypercholesterolemia and atherosclerosis. |
| IC 50 | Human Endogenous Metabolite |
EPA Preparation Products And Raw materials
